DUBLIN, Ireland, May 26, 2017 (GLOBE NEWSWIRE) -- Horizon Pharma plc HZNP, a biopharmaceutical company focused on improving patients' lives by identifying, developing, acquiring and commercializing differentiated and accessible medicines that address unmet medical needs, announced today that the company will participate at the following conferences in June:
Jefferies 2017 Global Healthcare Conference
- Date: June 6, 2017
- Presentation Time: 11:30 a.m. ET
- Location: New York, NY
The JMP Securities Life Science Conference
- Presentation Date: June 21, 2017
- Presentation Time: 1:30 p.m. ET
- Location: New York, NY
The conferences presentations will be webcast live and may be accessed by visiting Horizon's website at http://ir.horizon-pharma.com.
About Horizon Pharma plc
Horizon Pharma plc is a biopharmaceutical company focused on improving patients' lives by identifying, developing, acquiring and commercializing differentiated and accessible medicines that address unmet medical needs. The Company markets 11 medicines through its orphan, rheumatology and primary care business units. For more information, please visit www.horizonpharma.com. Follow @HZNPplc on Twitter or view careers on our LinkedIn page.
Contacts:
Investors: | U.S. Media: |
Tina Ventura | Geoff Curtis |
Senior Vice President, | Senior Vice President, |
Investor Relations | Corporate Affairs & Chief Communications Officer |
investor-relations@horizonpharma.com | media@horizonpharma.com |
Ruth Venning | Ireland Media: |
Executive Director, | Ray Gordon |
Investor Relations | Gordon MRM |
investor-relations@horizonpharma.com | ray@gordonmrm.ie |
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.